search
Back to results

The Relationship Between CFTR Gene Mutations and Exercise Capacity

Primary Purpose

Cystic Fibrosis

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fitness tracker
Sponsored by
Virginia Commonwealth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Cystic Fibrosis focused on measuring Exercise

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cystic fibrosis patient who has been tested positive for a CF mutation of class 1-5.
  • Part of the VCU cystic fibrosis program.
  • Above 18 years old.

Exclusion Criteria:

  • Has not been tested positive for a known CF mutation.
  • Not a part of the VCU cystic fibrosis program.
  • Cannot be under 18 years old.

Sites / Locations

  • Virginia Commonwealth University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Exercise trackers

Arm Description

Fitbit physical activity trackers

Outcomes

Primary Outcome Measures

Change in weekly mileage
Participants will report their weekly mileage in a REDCap form

Secondary Outcome Measures

Full Information

First Posted
December 1, 2021
Last Updated
September 9, 2022
Sponsor
Virginia Commonwealth University
Collaborators
Cystic Fibrosis Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05157646
Brief Title
The Relationship Between CFTR Gene Mutations and Exercise Capacity
Official Title
The Relationship Between CFTR Gene Mutations and Exercise Capacity
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Withdrawn
Why Stopped
Student was unable to start the project due to time constraints
Study Start Date
August 2022 (Anticipated)
Primary Completion Date
November 2022 (Anticipated)
Study Completion Date
November 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Virginia Commonwealth University
Collaborators
Cystic Fibrosis Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study will explore the effect of mutation severity on exercise capacity. Through a better understanding of the association between mutation severity and exercise capacity, clinicians will be more able to predict a given patient's level of independent functioning based on their genes, which is essential information that patients' families want to know upon diagnosis.
Detailed Description
Cystic fibrosis (CF) is a disease that disrupts the lungs. With an average survival of 40.7 years, this condition affects around 30,000 in the US. Most commonly seen in among those of European descent, CF is present in about 1 in every 2,500 Caucasian newborns. A genetic mutation causes a thick and sticky mucus production in the lungs. Thus, CF patients are more likely to have respiratory failure and lung infections. These symptoms of CF vary among patients and primarily depend on the severity of the gene mutations.Currently, there is not a lot of literature on the relationship between CFTR genes and exercise capacity, highlighting the relevance of this study. This study is expected to last at least 10 weeks. Participants will be given a Fitbit tracker at the beginning of the study to wear during their participation. Participants are asked to engage in their normal level of physical activity. No one from the research team will have direct access to their Fitbit information. In other words, participants will create an account on the Fitbit website and only participants will be able to see the information on there. A weekly survey about their Fitbit mileage will be given by a research member via phone. The weekly survey will also ask more opinionated questions, regarding any updates on their attitudes toward exercise. At the conclusion of this 10-week study, participants will have the option of keeping their Fitbit tracker. About 50 participants are expected to enroll in this study. At any point of the study, participants will be given the freedom to withdraw their participation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Exercise

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise trackers
Arm Type
Experimental
Arm Description
Fitbit physical activity trackers
Intervention Type
Behavioral
Intervention Name(s)
Fitness tracker
Intervention Description
Participants will be asked to wear a Fitbit fitness tracker and report their fitness activity to the study team
Primary Outcome Measure Information:
Title
Change in weekly mileage
Description
Participants will report their weekly mileage in a REDCap form
Time Frame
baseline to 10 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cystic fibrosis patient who has been tested positive for a CF mutation of class 1-5. Part of the VCU cystic fibrosis program. Above 18 years old. Exclusion Criteria: Has not been tested positive for a known CF mutation. Not a part of the VCU cystic fibrosis program. Cannot be under 18 years old.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nauman Chaudary, MD
Organizational Affiliation
Virginia Commonwealth University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Relationship Between CFTR Gene Mutations and Exercise Capacity

We'll reach out to this number within 24 hrs